2YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
BT-11 | BT11 | 1912399-75-7 |
AZD 1283 | AZD-1283 | 919351-41-0 |
CC-115 | CC-115 | 1228013-15-7 |
C-DIM 12 | C-DIM12 | 178946-89-9 |
N-((4,5-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine | SR-3029 | 1454585-06-8 |
NSC-247030 | NSC247030;NSC-247030;NSC 247030 | 114727-43-4 |
LOXIGLUMIDE | 氯谷胺 | 107097-80-3 |
LAVENDUSTIN B | 薰草菌素B | 125697-91-8 |
SU4312 | SU 4312;NSC 86429;SU-4312;NSC-86429 | 5812-07-7 |
Ticlopidine hydrochloride | 盐酸噻氯匹定 | 53885-35-1 |
Loflucarban | 氯氟卡班 | 790-69-2 |
Palifosfamide | 帕利伐米 | 31645-39-3 |
Clanfenur | 克兰氟脲 | 51213-99-1 |
2-amino-1-(4-chlorobenzyl)-5-trifluoromethylbenzimidazole | 150493-34-8 | 150493-34-8 |
SUFUGOLIX | SUFUGOLIX | 308831-61-0 |
(E)-2-cyano-3-(4-hydroxy-3,5-diisopropylphenyl)-N-(3-phenylpropyl)acrylamide | (E)-2-氰基-3-(4-羟基-3,5-二异丙苯基)-N-(3-苯基丙基)丙烯酰胺 | 168835-82-3 |
4-[(Diethylamino)methyl]-N-[2-(2-methoxyphenyl)ethyl]-N-(3R)-3-pyrrolidinylbenzamide | 4-[(二乙基氨基)甲基]-N-[2-(2-甲氧基苯基)乙基]-N-(3R)-3-吡咯烷基苯甲酰胺 | 947303-87-9 |
CAY10602 | 1-(4-氟苯基)-3-(苯磺酰基)-1H-吡咯并[2,3-B]喹喔啉-2-胺 | 374922-43-7 |
Mycro 3 | 944547-46-0 | 944547-46-0 |
SU5205 | SU 5205; SU-5205; SU5205 | 3476-86-6 |
CPI-1189 | N-叔丁基-4-乙酰氨基苯甲酰胺 | 183619-38-7 |
NIH-12848 | 化合物NIH12848 | 959551-10-1 |
IRAK4-IN-1 | 1820787-94-7 | 1820787-94-7 |
SKI II | 鞘氨醇激酶抑制剂 | 312636-16-1 |
5-(2-formyl-3-hydroxyphenoxy)valeric acid | VELARESOL; BW 12C79; BW-12C79; BW12C79; BW 12C; BW-12C; BW12C | 77858-21-0 |
trovirdine | 曲韦定 | 149488-17-5 |
Phenithionate | 5MG | 83538-74-3 |
S3I-201 | S3I-201 | 501919-59-1 |
4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide, 97% | 4-甲氧基-N-(2,4,6-三甲基苯)苯磺酰胺 | 349085-82-1 |
5-(4-iodobenzylidene)rhodanine | 5-(4-碘苯亚甲基)罗丹宁 | 90947-00-5 |
UAMC 00039 dihydrochloride | UAMC 00039 DIHYDROCHLORIDE | 697797-51-6 |
4-O-[2-(2,5-dioxopyrrolidin-1-yl)ethyl] 1-O-methyl (E)-but-2-enedioate | 2-(2,5-二氧代吡咯烷-1-基)乙基甲基富马酸酯 | 1577222-14-0 |
AZD0156 | AZD0156 | 1821428-35-6 |
ML364 | 2-(4-甲基苯磺胺基)-N-(4-苯基噻唑-2-基)-4-三氟甲基苯甲酰胺 | 1991986-30-1 |
4'-CHLORO-3-METHOXYCINNAMANILIDE | 3-(4-氯苯基)-N-(3-甲氧基苯基)-2-丙烯酰胺 | 472981-92-3 |
IC 261 | 3-(2,4,6-三甲氧基苯亚甲基)吲哚啉-2-酮 | 186611-52-9 |
1,3-Bis(4-aminophenyl)urea | 1,3-二(4-氨基苯基)脲 | 4550-72-5 |
AGI 1067 | AGI 1067 | 216167-82-7 |
Phenol, 2-Methoxy-5-[[[(1E)-2-(2,4,6-triMethoxyphenyl)ethenyl]sulfonyl]Methyl]-, 1-(dihydrogen phosphate) | BRICICLIB | 865783-99-9 |
EBE-A 22 | N-(3-溴苯基)-6,7-二甲氧基-N-甲基-4-喹唑啉胺 | 229476-53-3 |
R 112 (pharMaceutical) | R112 | 575474-82-7 |
Probucol Disuccinate | 普罗布考 | 216168-45-5 |
3,4-Dimethoxy-N-(5-phenyl-1H-pyrazol-3-yl)-benzamide | 3,4-二甲氧基-N-(5-苯基-1H-吡唑-3-基)苯甲酰胺 | 942655-44-9 |
ML 18 | (S)-3-(1H-吲哚-3-基)-N-((1-(4-甲氧基苯基)环己基)甲基)-2-(3-(4-硝基苯基)脲基)丙酰胺 | 1422269-30-4 |
6,4''-DIHYDROXYAURONE | Hispidol | 5786-54-9 |
4-Oxofenretinide | 4-氧代维甲酰酚胺 | 865536-65-8 |
NQDI 1 | NQDI 1 | 175026-96-7 |
GK921 | 1025015-40-0 | 1025015-40-0 |
SU 4942 | SU 4942; SU-4942; SU4942 | 76086-99-2 |
U 19963 | U 19963;U-19963 ;U19963 | 404-52-4 |
hVEGF-IN-1 | 1637443-98-1 | 1637443-98-1 |
LAVENDUSTIN C | N-(2,5-二羟基苄基)-5-氨基水杨酸 | 125697-93-0 |
3,4-dichlorophenyl propenylisobutylamide | LVGUIDINGAN;3;4-DICHLOROPHENYL PROPENYLISOBUTYLAMIDE | 82351-05-1 |
N-(4-BROMO-2-METHYLPHENYL)-2-CHLOROACETAMIDE | N-(4-溴-2-甲基苯基)-2-氯乙酰胺 | 96686-51-0 |
TIMTEC-BB SBB006342 | NSC-191412;NSC191412 | 370-16-1 |
Octanoic acid, 6,8-bis[(phenylMethyl)thio]- | 6,8-双(苄硫基)辛酸 | 95809-78-2 |
Lu AF21934 | (1S,2R)-N1-(3,4-二氯苯基)环己烷-1,2-二甲酰胺 | 1445605-23-1 |
PGD2-inhibitor | 2-(3-(6-(2-(2,4-二氯苯基)乙基氨基)-2-甲氧基嘧啶-4-基)苯基)-2-甲基丙酸 | 885066-67-1 |
AG 1406 | AG1406;AG-1406 | 71308-34-4 |
N-ACETYLPROCAINAMIDE HYDROCHLORIDE | N-盐酸乙酰普鲁卡胺 | 34118-92-8 |
TYRPHOSTIN B46 | TYRPHOSTIN AG 555 | 133550-34-2 |
2-Propenamide, 2-cyano-3-(4-hydroxy-3,5-bis(1-methylethyl)phenyl)- | 106392-48-7 | 106392-48-7 |
Tasquinimod | 他喹莫德 | 254964-60-8 |
7-OXO-7H-BENZIMIDAZO[2,1-A]BENZ[DE]ISOQUINOLINE-3-CARBOXYLIC ACID ACETATE | STO-609 | 52029-86-4 |
2-PyriMidinaMine,4-Methyl-N-[5-Methyl-4-(1H-pyrazol-4-yl)-2-thiazolyl]- | ADX-88178 | 1235318-89-4 |
DCC-2618 | DCC-2618 | 1225278-16-9 |
GSK583 | 6-(叔丁基磺酰基)-N-(5-氟-1H-吲唑-3-基)喹啉-4-胺 | 1346547-00-9 |
IMR-1 | [2-甲氧基-4-[(4-氧代-2-硫代-5-噻唑烷亚基)甲基]苯氧基]乙酸乙酯 | 310456-65-6 |
CHMFL-BMX-078 | 化合物CHMFL-BMX-078 | 1808288-51-8 |
KDM4D-IN-1 | 2098902-68-0 | 2098902-68-0 |
3-(4-ISOPROPYLBENZYLIDENYL)INDOLIN-2-ONE | SU4313 SU-4313 SU 4313 | 186611-55-2 |
1,4-DIAMIDOXIMOBUTANE | NSC 70868;NSC-70868;NSC70868 | 15347-78-1 |
5-(4-Hydroxyphenyl)-3H-1,2-dithiole-3-thione | 5-(4-羟基苯基)-3H-1,2-二硫杂环戊烯-3-硫酮 | 18274-81-2 |
4-P-PDOT | 4-P-PDOT | 134865-74-0 |
VU 0155041 | VU0155041 | 1093757-42-6 |
BVT-14225 | 376638-65-2 | 376638-65-2 |
SU5214 | 合物SU 5214 | 186611-04-1 |
MTX 211 | MTX-211 | 1952236-05-3 |
NSC 80538 | NSC 80538;NSC-80538;NSC80538 | 370-26-3 |
VALROCEMIDE | N-丙戊酰基甘氨酰胺 | 92262-58-3 |
Ticlopidine | 噻氯匹定 | 55142-85-3 |
rac BHFF | RACBHFF;RAC-BHFF;RAC BHFF | 123557-91-5 |
I-CBP 112 | 化合物I-CBP112 | 1640282-31-0 |
GAL-021 | GAL021 | 1380341-99-0 |
CPI-455 | 6-异丙基-7-氧代-5-苯基-4,7-二氢吡唑并[1,5-A]嘧啶-3-腈 | 1628208-23-0 |
XL-652 | 化合物XL652 | 918348-67-1 |
SPI-112 | (Z)-3-(2-(5-(N-(4-氟苄基)氨磺酰基)-2-氧代二氢吲哚-3-亚基)肼基)苯甲酸 | 1051387-90-6 |
R162 | R162 | 64302-87-0 |
RO 5028442 | RO 5028442 | 920022-47-5 |
Nicaraven | 烟拉文 | 79455-30-4 |
CP-466722 | CP466722 | 1080622-86-1 |
TD-198946 | TD-198946 | 364762-86-7 |
ASP-9521 | 1-[1-[(5-甲氧基-1H-吲哚-2-基)羰基]哌啶-4-基]-2-甲基丙-2-醇 | 1126084-37-4 |
Y16 | 429653-73-6 | 429653-73-6 |
CID-49830258 | ML240 | 1346527-98-7 |
IMR-1A | 331862-41-0 | 331862-41-0 |
TYRPHOSTIN RG 14620 | TYRPHOSTIN RG 14620 | 136831-49-7 |
SDZ285-428 | N-(2-(1H-咪唑-1-基)-2-苯乙基)-4'-氯-[1,1'-联苯]-4-甲酰胺 | 174262-13-6 |
SB756050 | 447410-57-3 | 447410-57-3 |
TYRPHOSTIN RG 13022 | RG-13022 | 136831-48-6 |
联系方式